Adjuvant therapy for cutaneous malignant melanoma

Surg Clin North Am.

1986 • 8,793 citations

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma

1992 • 4,391 citations

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1991 • 3,493 citations

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1996 • 2,073 citations

Cancer: Principles and Practice of Oncology

1994 • 1,825 citations

The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control Trial

1978 • 1,634 citations

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

1994 • 1,108 citations

Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells

1980 • 1,094 citations

The Interferon System

1979 • 1,035 citations

Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up

1995 • 1,027 citations

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1993 • 986 citations

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1994 • 934 citations

Chemotherapy of Cancer

1958 • 874 citations

Randomized versus historical controls for clinical trials

1982 • 833 citations

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.

1994 • 771 citations

The Orderly Progression of Melanoma Nodal Metastases

1994 • 755 citations

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.

1992 • 730 citations

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.

1994 • 584 citations

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

1994 • 522 citations

Reporting on Methods in Clinical Trials

1982 • 503 citations

Immunological factors which influence response to immunotherapy in malignant melanoma.

1970 • 462 citations

Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine

1992 • 410 citations

Demonstration of antibodies against human malignant melanoma by immunofluorescence.

1968 • 390 citations

A Multifactorial Analysis of Melanoma

1981 • 368 citations

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.

1990 • 300 citations

A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous Melanoma

1982 • 282 citations

Multivariate Analysis

1983 • 280 citations

Lymphatic Drainage of Skin to a Sentinel Lymph Node in a Feline Model

1991 • 280 citations

Detection of Submicroscopic Lymph Node Metastases with Polymerase Chain Reaction in Patients with Malignant Melanoma

1994 • 280 citations

Drug-Induced Restoration of Cutaneous Delayed Hypersensitivity in Anergic Patients with Cancer

1973 • 264 citations

Sample Size Nomograms For Interpreting Negative Clinical Studies

1983 • 261 citations

Fraction size in external beam radiation therapy in the treatment of melanoma

1991 • 258 citations

An Additional Basic Science for Clinical Medicine: II. The Limitations of Randomized Trials

1983 • 257 citations

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.

1995 • 253 citations

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

1988 • 239 citations

BCG and Cancer

1974 • 238 citations

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

1987 • 224 citations

Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.

1984 • 224 citations

ŒSTROGEN RECEPTORS IN HUMAN MALIGNANT MELANOMA

1976 • 220 citations

Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.

1996 • 212 citations

Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study.

1996 • 206 citations

Management of Early-Stage Melanoma by Intraoperative Lymphatic Mapping and Selective Lymphadenectomy: An Alternative to Routine Elective Lymphadenectomy or “Watch and Wait”

1992 • 201 citations

Immunotherapy of Human Cancer

1983 • 174 citations

Ganglioside GM2 as a human tumor antigen (OFA-I-1).

1983 • 174 citations

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.

1993 • 173 citations

Prognostic Factors in Patients Undergoing Lymphadenectomy of Malignant Melanoma

1977 • 163 citations

Factors Prognostic for Survival in Patients with Malignant Melanoma Spread to the Regional Lymph Nodes

1982 • 163 citations

Spontaneous regression of human melanoma.Clinical and experimental studies

1960 • 156 citations

Polymerase Chain Reaction Detection of Circulating Melanocytes as a Prognostic Marker in Patients With Melanoma

1995 • 150 citations

Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes

1981 • 142 citations

Clinical Trials and Statistical Verdicts: Probable Grounds for Appeal

1983 • 139 citations

Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.

1991 • 135 citations

Adjuvant radiation therapy for regional nodal metastases from malignant melanoma. A randomized, prospective study

1978 • 133 citations

Characterization of the Inhibitory Effects of Retinoids on the In Vitro Growth of Two Malignant Murine Melanomas2

1978 • 132 citations

The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients

1992 • 128 citations

DTIC and combination therapy for melanoma: III. DTIC (NSC 45388) surgical adjuvant study COG PROTOCOL 7040

1981 • 126 citations

In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon‐γ and melphalan in isolation perfusion

1992 • 124 citations

Corynebacterium parvum as an immunotherapeutic anticancer agent.

1974 • 124 citations

Regional Radiotherapy as Adjuvant Treatment for Head and Neck Malignant Melanoma: Preliminary Results

1990 • 123 citations

A phase III randomized, doúble-blind, multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma

1995 • 121 citations

Inhibition of the Growth and Development of a Transplantable Murine Melanoma by Vitamin A

1975 • 116 citations

Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study

1995 • 111 citations

Immunotherapy of Human Cancer

1982 • 110 citations

Levamisole Inhibits and Cures a Solid Malignant Tumour and its Pulmonary Metastases in Mice

1972 • 110 citations

Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide.

1985 • 110 citations

A membrane antigen common to human cancer and fetal brain tissues.

1976 • 106 citations

Active Specific Immunotherapy of Melanoma with Allogeneic Cell Lysates Rationale, Results, and Possible Mechanisms of Actiona

1993 • 97 citations

Regional non-nodal metastases of cutaneous melanoma.

1986 • 94 citations

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma

1992 • 89 citations

Angiogenesis and the skin: A primer

1996 • 86 citations

Spontaneous regression of melanoma. Report of a case

1953 • 82 citations

Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.

1991 • 81 citations

Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.

1985 • 81 citations

Adjuvant Immunotherapy or Chemotherapy for Malignant Melanoma: Preliminary Report of the National Cancer Institute Randomized Clinical Trial

1981 • 79 citations

Pooled Analysis of the Efficacy of Bacille Calmette‐Guerin (BCG) Immunotherapy in Malignant Melanoma

1993 • 78 citations

A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.

1991 • 76 citations

Identification of tumour rejection antigens recognized by T lymphocytes.

1992 • 72 citations

Understanding and evaluating clinical trials

1996 • 71 citations

A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I):Prognostic factors analysis and preliminary results of immunotherayp

1982 • 70 citations

Controlled trial of active immunotherapy in management of stage IIB malignant melanoma.

1977 • 67 citations

Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survival

1994 • 67 citations

Studies of interferons in the therapy of melanoma.

1991 • 67 citations

Favorable prognostic factors in recurrent and metastatic melanoma

1996 • 67 citations

An Additional Basic Science for Clinical Medicine: III. The Challenges of Comparison and Measurement

1983 • 65 citations

Active Immunotherapy of Human Melanoma Exploiting the Immunopotentiating Effects of Cyclophosphamide

1988 • 63 citations

Cutaneous Malignant Melanoma: Prognostic Guidelines for Physicians and Patients

1982 • 63 citations

Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine

1995 • 62 citations

Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma.

1991 • 60 citations

Positron Emission Tomography and Ultrasonography

1995 • 58 citations

Evaluation of efficacy of adjuvant rIFN-alfa-2a in melanoma patients with regional nodal metastases (abstract)

1995 • 57 citations

The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma

1990 • 57 citations

Hyperthermic perfusion with chemotherapy for melanoma of the extremities

1989 • 55 citations

Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma

1983 • 54 citations

Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC protocol 18781)

1993 • 53 citations

Prognosis of Thick Cutaneous Melanoma of the Trunk and Extremity

1990 • 52 citations

A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma.

1987 • 52 citations

The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases.

1995 • 49 citations

Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.

1978 • 47 citations

DTIC and combination therapy for melanoma

1981 • 47 citations

Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study.

1994 • 47 citations

Late Recurrence (Beyond Ten Years) of Cutaneous Malignant Melanoma

1984 • 46 citations

ADJUVANT BCG IMMUNOTHERAPY FOR MALIGNANT MELANOMA?

1983 • 45 citations

Historic milestones in curative chemotherapy.

1979 • 44 citations

Illusion and reality: practical pitfalls in interpreting clinical trials.

1984 • 41 citations

Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.

1987 • 40 citations

Randomized Trial of High Dose Chemotherapy With Autologous Bone Marrow Support as Adjuvant Therapy for High-Risk, Multi-Node Positive Malignant Melanoma

1993 • 40 citations

The Role of Selective Lymphadenectomy in the Management of Patients with Malignant Melanoma

1995 • 39 citations

The female superiority in survival in clinical stage. II. Cutaneous malignant melanoma

1982 • 38 citations

Natural history of malignant melanoma as related to therapy.

1976 • 38 citations

Multivariate analysis. Some guidelines for physicians

1983 • 34 citations

Adjuvant immunotherapy of malignant melanoma

1979 • 34 citations

The significance of conversion of skin reactivity to efficacy of bacillus Calmette-Gu�rin (BCG) vaccinations given immediately after radical surgery in stage II melanoma patients

1989 • 34 citations

Double blind randomized prospective trial of levamisole/placebo in stage I cutaneous malignant melanoma.

1987 • 34 citations

A Prospective, Randomized Controlled Trial of Megestrol Acetate Among High-Risk Patients with Resected Malignant Melanoma

1989 • 33 citations

New approaches in metastatic melanoma: biological and molecular targeted therapies

2007 • 32 citations

Randomized controlled trial of transfer factor in stage II malignant melanoma

1983 • 30 citations

A randomized trial of adjuvant chemotherapy and immunotherapy in stage I and stage II cutaneous melanoma. An interim report

1985 • 30 citations

Randomized trial of adjuvant therapy for “high risk” primary malignant melanoma

1979 • 29 citations

Randomized study of Corynebacterium parvum adjuvant therapy following surgery for (Stage II) malignant melanoma

1986 • 29 citations

Improved Graphs for Calculating Sample Sizes When Comparing Two Independent Binomial Distributions

1979 • 27 citations

Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence

1978 • 27 citations

A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma

1988 • 26 citations

Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group Study.

1987 • 26 citations

Adjuvant therapy of cutaneous malignant melanoma: A critical review

1985 • 26 citations

Predictors of Late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis

1983 • 26 citations

Adjuvant treatment of malignant melanoma with DTIC + estracyt or BCG

1987 • 25 citations

A quality‐adjusted survival meta‐analysis of adjuvant chemotherapy for premenopausal breast cancer

1995 • 25 citations

Multimodal Primary Cancer Treatment (Adjuvant Chemotherapy): Current Results and Future Prospects

1979 • 24 citations

A review of transfer factor immunotherapy in cancer

1974 • 23 citations

Clinical Activity of a Polyvalent Melanoma Antigen Vaccine

1995 • 23 citations

The use of tumour necrosis factor (TNF) in isolated perfusion: results and side effects. The NCI results.

1994 • 20 citations

Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine.

1991 • 19 citations

Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma.

1979 • 18 citations

Comparison of the Potentiation of Specific Tumor Immunity in Mice by Corynebacterium parvum or BCG 2

1976 • 18 citations

Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy

1977 • 17 citations

Patients and physicians as obstacles to a randomized trial.

1981 • 16 citations

Regional lymph node dissection for malignant melanoma of the extremities.

1981 • 16 citations

Surgical Adjuvant Therapy for Malignant Melanoma

1981 • 16 citations

Role of beta1 integrins in melanocyte cell spreading and migration on ECM and their possible role in the process of tumor invasion and metastasis

1994 • 14 citations

BCG immunotherapy in stage I melanoma patients

1986 • 14 citations

Randomized controlled trial of adjuvant chemoimmunotherapy with DTIC and BCG after complete excision of primary melanoma with a poor prognosis or melanoma metastases.

1983 • 13 citations

Adjuvant Chemotherapy for Cancer

1977 • 12 citations

Phase III adjuvant studies in operable malignant melanoma (review).

1987 • 11 citations

Adjuvant Treatment in Stage I and II Malignant Melanoma: A Randomized Trial between Chemoimmunotherapy and Immunotherapy

1991 • 10 citations

Regional lymph node dissection for malignant melanoma of the extremities

1981 • 8 citations

Adjuvant chemotherapy in cancer.

1977 • 4 citations

Cancer Vaccines, Disappointing In the Past, Show Promise

1996 • 3 citations

Adjuvant Cancer Therapy: Rationale for Its Use

1981 • 2 citations

Endocrinology of melanoma

1996 • 2 citations

Deleted Work

1955 • 0 citations